Follicular Retention Protocol
Clinically evaluated protocols for male pattern hair loss — 5α-reductase inhibitors and topical vasodilators prescribed by independent licensed providers when clinically appropriate. Results require ongoing treatment and take months to emerge.
Three Steps to Clinical Intake
The ForgeVita platform routes your intake to an independent licensed clinical practice in your state. Here's what to expect.
Start Assessment
Complete your 5-minute health intake at no cost. Your state is verified for routing availability before any clinical workflow begins.
Clinical Matching
The secure clinical partner workflow discloses the independent provider entity, applicable consents, and all charges before your evaluation begins.
Receive If Prescribed
If treatment is clinically approved by the independent provider, the pharmacy partner fulfills and ships your medication in plain, unbranded packaging.
Understanding Androgenetic Alopecia
Clinical context for patients researching finasteride and minoxidil treatment.
Androgenetic alopecia (male pattern baldness) is the most common form of hair loss in men, affecting over 50% of men by age 50 and a significant proportion earlier. It follows a characteristic pattern — typically beginning at the temples and crown — and progresses at a rate that varies considerably by individual.
The primary driver is dihydrotestosterone (DHT), a potent androgen converted from testosterone by the enzyme 5α-reductase. In genetically susceptible hair follicles, DHT binds to androgen receptors and progressively miniaturizes the follicle, shortening the growth (anagen) phase and eventually causing the follicle to stop producing visible hair.
The most clinically studied treatments work either by blocking DHT conversion (finasteride, dutasteride) or by extending the anagen phase and increasing blood flow to the follicle (minoxidil). These mechanisms are distinct and may be used individually or in combination at the provider's discretion.
Treatment is most effective when started early in the hair loss process, before follicles have been permanently miniaturized. Ongoing daily use is required — discontinuing treatment typically leads to resumed hair loss within months. All protocols require evaluation and prescription by an independent licensed provider.
Available Treatment Approaches
The independent licensed provider evaluates which option is most appropriate for your pattern, history, and individual clinical circumstances.
Oral Finasteride
A 5α-reductase type II inhibitor that blocks DHT conversion. Taken daily. Requires ongoing use to maintain effect. Provider evaluation required due to contraindications and potential side effects.
Topical Minoxidil
A vasodilator applied directly to the scalp that extends the anagen (growth) phase and increases follicular blood supply. Available OTC but provider-evaluated dosing and formulation may differ.
Oral Minoxidil
Low-dose oral minoxidil is an off-label option evaluated by the independent provider. Systemic absorption requires cardiovascular screening and provider monitoring. Not appropriate for all patients.
Combination Approaches
Provider may recommend finasteride combined with topical or oral minoxidil based on pattern severity, progression rate, and individual clinical judgment. Disclosed in the clinical workflow.
Frequently Asked Questions
Transparency about how treatment works, what to expect, and what it costs.
How does treatment work?
How much does it cost?
What are the side effects?
Do I need to use it forever?
What type of hair loss is treated?
Which states is this available in?
Explore Other Programs
Additional clinical protocols available through the ForgeVita platform.
Ready to Begin Your Assessment?
Complete the 5-minute intake. State availability is verified during the process. No payment required to start.
Start Assessment